These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 18628462)
1. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Cottrell WJ; Paquette AD; Keymel KR; Foster TH; Oseroff AR Clin Cancer Res; 2008 Jul; 14(14):4475-83. PubMed ID: 18628462 [TBL] [Abstract][Full Text] [Related]
2. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer. Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058 [TBL] [Abstract][Full Text] [Related]
3. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Itkin A; Gilchrest BA Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516 [TBL] [Abstract][Full Text] [Related]
5. A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer. Zeitouni NC; Sunar U; Rohrbach DJ; Paquette AD; Bellnier DA; Shi Y; Wilding G; Foster TH; Henderson BW Dermatol Surg; 2014 Dec; 40(12):1390-4. PubMed ID: 25393353 [TBL] [Abstract][Full Text] [Related]
6. Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT. Wang KK; Cottrell WJ; Mitra S; Oseroff AR; Foster TH Lasers Surg Med; 2009 Nov; 41(9):686-96. PubMed ID: 19802891 [TBL] [Abstract][Full Text] [Related]
7. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas. Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097 [TBL] [Abstract][Full Text] [Related]
8. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268 [TBL] [Abstract][Full Text] [Related]
9. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. af Klinteberg C; Enejder AM; Wang I; Andersson-Engels S; Svanberg S; Svanberg K J Photochem Photobiol B; 1999 Apr; 49(2-3):120-8. PubMed ID: 10392462 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772 [TBL] [Abstract][Full Text] [Related]
12. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Choudry K; Brooke RC; Farrar W; Rhodes LE Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205 [TBL] [Abstract][Full Text] [Related]
13. Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Finlay JC; Conover DL; Hull EL; Foster TH Photochem Photobiol; 2001 Jan; 73(1):54-63. PubMed ID: 11202366 [TBL] [Abstract][Full Text] [Related]
14. Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach. Vaucher L; Jichlinski P; Lange N; Ritter-Schenk C; van den Bergh H; Kucera P Lasers Surg Med; 2007 Jan; 39(1):67-75. PubMed ID: 17096415 [TBL] [Abstract][Full Text] [Related]
15. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of nodular basal cell carcinoma with multifiber contact light delivery. Thompson MS; Andersson-Engels S; Svanberg S; Johansson T; Palsson S; Bendsoe N; Derjabo A; Kapostins J; Stenram U; Spigulis J; Svanberg K J Environ Pathol Toxicol Oncol; 2006; 25(1-2):411-24. PubMed ID: 16566732 [TBL] [Abstract][Full Text] [Related]
17. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy. Blake E; Allen J; Thorn C; Shore A; Curnow A Lasers Med Sci; 2013 May; 28(3):997-1005. PubMed ID: 22926533 [TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis. Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060 [TBL] [Abstract][Full Text] [Related]
19. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen. Liu B; Farrell TJ; Patterson MS Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331 [TBL] [Abstract][Full Text] [Related]
20. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. Shen SC; Lee WR; Fang YP; Hu CH; Fang JY J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]